BridgeBio Oncology Therapeutics, Inc. 8-K
Accession 0001213900-25-075190
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 12, 8:54 PM ET
Size
3.4 MB
Accession
0001213900-25-075190
Documents
- 8-Kea0250662-8k_bridge.htmPrimary
CURRENT REPORT
- EX-3.1ea025066201ex3-1_bridge.htm
BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. CERTIFICATE OF INCORPORATION
- EX-3.2ea025066201ex3-2_bridge.htm
BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. BYLAWS
- EX-10.1ea025066201ex10-1_bridge.htm
AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT, DATED AS OF AUGUST 11, 2025, BY AND BETWEEN PUBCO, HELIX HOLDINGS II, LLC
- EX-10.3ea025066201ex10-3_bridge.htm
LOCK-UP AGREEMENT, DATED AS OF AUGUST 11, 2025, BY AND BETWEEN HELIX ACQUISITION CORP. II, HELIX HOLDINGS II, LLC
- EX-10.12ea025066201ex10-12_bridge.htm
EMPLOYEE OFFER LETTER, DATED APRIL 30, 2024, BY AND BETWEEN BBOT AND ELI WALLACE
- EX-10.13ea025066201ex10-13_bridge.htm
AMENDMENT TO THE EMPLOYEE OFFER LETTER, DATED SEPTEMBER 10, 2024, BY AND BETWEEN BBOT AND ELI WALLACE
- EX-10.14ea025066201ex10-14_bridge.htm
EMPLOYEE OFFER LETTER, DATED APRIL 30, 2024, BY AND BETWEEN BBOT AND PEDRO BELTRAN
- EX-10.15ea025066201ex10-15_bridge.htm
EMPLOYEE OFFER LETTER, DATED AUGUST 12, 2024, BY AND BETWEEN BBOT AND YONG BEN
- EX-10.16ea025066201ex10-16_bridge.htm
EMPLOYMENT AGREEMENT, DATED AUGUST 11, 2025, BY AND BETWEEN THE REGISTRANT AND ELI WALLACE
- EX-10.17ea025066201ex10-17_bridge.htm
EMPLOYMENT AGREEMENT, DATED AUGUST 11, 2025, BY AND BETWEEN THE REGISTRANT AND PEDRO BELTRAN
- EX-10.18ea025066201ex10-18_bridge.htm
EMPLOYMENT AGREEMENT, DATED AUGUST 11, 2025, BY AND BETWEEN THE REGISTRANT AND YONG BEN
- EX-10.19ea025066201ex10-19_bridge.htm
EMPLOYMENT AGREEMENT, DATED AUGUST 11, 2025, BY AND BETWEEN THE REGISTRANT AND UNEEK MEHRA
- EX-10.20ea025066201ex10-20_bridge.htm
THERAS, INC. 2016 EQUITY INCENTIVE PLAN, AND FORMS OF AWARD AGREEMENTS THEREUNDER
- EX-10.21ea025066201ex10-21_bridge.htm
BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. 2025 STOCK OPTION AND INCENTIVE PLAN AND FORMS OF AWARD AGREEMENTS THEREUNDER
- EX-10.22ea025066201ex10-22_bridge.htm
BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. 2025 EMPLOYEE STOCK PURCHASE PLAN
- EX-10.23ea025066201ex10-23_bridge.htm
BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. EXECUTIVE SEVERANCE PLAN
- EX-10.24ea025066201ex10-24_bridge.htm
BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. SENIOR EXECUTIVE CASH INCENTIVE BONUS PLAN
- EX-10.25ea025066201ex10-25_bridge.htm
BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY
- EX-10.26ea025066201ex10-26_bridge.htm
FORM OF DIRECTOR INDEMNIFICATION AGREEMENT
- EX-10.27ea025066201ex10-27_bridge.htm
FORM OF OFFICER INDEMNIFICATION AGREEMENT
- EX-14.1ea025066201ex14-1_bridge.htm
CODE OF BUSINESS CONDUCT AND ETHICS
- EX-16.1ea025066201ex16-1_bridge.htm
LETTER FROM WITHUMSMITH+BROWN, PC TO THE U.S. SECURITIES AND EXCHANGE COMMISSION DATED AUGUST 11, 2025
- EX-21.1ea025066201ex21-1_bridge.htm
SUBSIDIARIES OF THE REGISTRANT
- EX-99.1ea025066201ex99-1_bridge.htm
THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS OF BBOT AS OF JUNE 30, 2025 AND FOR THE SIX MONTHS ENDED JUNE 30, 2025 AND 2024
- EX-99.2ea025066201ex99-2_bridge.htm
THE UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF PUBCO AS OF AND FOR THE SIX MONTHS ENDED JUNE 30, 2025 AND FOR THE YEAR ENDED DECEMBER 31, 2024
- EX-99.3ea025066201ex99-3_bridge.htm
MANAGEMENT'S DISCUSSION AND ANALYSIS OF THE FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF BBOT FOR THE SIX MONTHS ENDED JUNE 30, 2025 AND 2024
- EX-99.4ea025066201ex99-4_bridge.htm
PRESS RELEASE, DATED AUGUST 11, 2025
- GRAPHICex10-12_001.jpg
GRAPHIC
- GRAPHICex10-14_001.jpg
GRAPHIC
- GRAPHICex10-15_001.jpg
GRAPHIC
- GRAPHICex99-4_001.jpg
GRAPHIC
- EX-101.SCHhlxb-20250811.xsd
XBRL SCHEMA FILE
- EX-101.DEFhlxb-20250811_def.xml
XBRL DEFINITION FILE
- EX-101.LABhlxb-20250811_lab.xml
XBRL LABEL FILE
- EX-101.PREhlxb-20250811_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-25-075190-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLea0250662-8k_bridge_htm.xml
IDEA: XBRL DOCUMENT
Issuer
BridgeBio Oncology Therapeutics, Inc.
CIK 0001869105
Related Parties
1- filerCIK 0001869105
Filing Metadata
- Form type
- 8-K
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 12, 8:54 PM ET
- Size
- 3.4 MB